Estrogensecreting

Estrogen-secreting refers to tissues or tumors that produce estrogen, a group of steroid hormones including estradiol, estrone, and estriol. In humans, estrogens are produced mainly by the ovaries, during pregnancy by the placenta, and by adipose tissue after menopause; smaller amounts are generated in the testes and brain. Ovarian production occurs in granulosa cells via aromatase, which converts androgens such as androstenedione and testosterone into estrogens under follicle-stimulating hormone control. Placental estrogen synthesis supports pregnancy and contributes to maternal physiological changes. In postmenopausal individuals, adipose tissue becomes a more important source of estrogen, influencing bone density and cardiovascular risk.

Pathology and clinical significance: Estrogen-secreting tumors are most commonly sex cord-stromal tumors of the ovary, especially granulosa cell tumors, which can secrete excess estrogen. Presentation varies with age and hormonal milieu and may include abnormal uterine bleeding, endometrial hyperplasia, or precocious puberty in children. A subset of patients may have breast tenderness, changes in body habitus, or infertility. Diagnosis typically involves measurement of serum estradiol and inhibin B, imaging to identify an ovarian mass, and surgical excision with histopathology for confirmation.

In clinical practice, recognizing estrogen-secreting activity is important because management differs from estrogen-deficient or non-secreting states and can affect endometrial health and fertility. Normal placental estrogen production and regulated ovarian estrogen synthesis are essential for development and reproduction; dysregulated or tumor-driven estrogen secretion requires targeted evaluation and treatment.